Defense World
22 Aug 2026, 07:05 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
5 claims · each scored for market impact
West Pharmaceutical Services reported Q2 earnings of $2.37 EPS and revenue of $872.30 million, beating analyst estimates of $2.08 EPS and $839.98 million. — Strong earnings and revenue beats typically drive immediate positive price action and validate growth trajectories.
+0.60BlackRock Inc. initiated a significant new position in West Pharmaceutical Services valued at approximately $2.39 billion during the second quarter. — Massive capital inflows from a top-tier institutional manager signal strong institutional conviction and provide a price floor.
+0.50Multiple analysts recently raised price targets for WST, with Citigroup raising its objective to $412.00 and KeyCorp boosting its target to $390.00. — Upward revisions in price targets suggest expanding valuation ceilings and positive sentiment among sell-side analysts.
+0.40Continue reading
6 related stories
Search tags
West Pharmaceutical Services issued Q3 2026 EPS guidance of 2.140-2.240 and FY 2026 guidance of 8.850-9.050. — Concrete forward guidance allows the market to model future earnings, reducing uncertainty.
+0.30Institutional ownership of West Pharmaceutical Services is very high, with 93.90% of the stock held by hedge funds and other institutional investors. — High institutional concentration reduces retail volatility but can lead to sharp moves if a major fund decides to exit.
+0.10Which stocks this story touches
The company reported earnings and revenue beats, received multiple analyst upgrades/buy ratings, and saw significant institutional buying.
Advisors Capital Management LLC took a new multimillion-dollar position in the company.
Aberdeen Group plc purchased over 330,000 shares of the company.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Defense World
3h ago
